Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
  Sudeep Pharma Ltd
Registered Office: 129/1/A GIDC Estate Nandesari, , Vadodara - 391340 , Gujarat , India.
Phone : +91 265 284 0656/329 1354   Fax:
Email :  cs.sudeep@sudeepgroup.com  
Website :  https://www.sudeeppharma.com
Initial public offer of 15,092,749 equity shares of face value of Re.1/- each ("equity shares") of Sudeep Pharma Limited ("company") for cash at a price of 593/- per equity share (including a share premium of 592/- per equity share) ("offer price") aggregating to 895.00 crores comprising a fresh issue of 1,602,023 equity shares of face value of Re.1/- aggregating to 95.00 crores by the company ("fresh issue") and an offer for sale of 13,490,726 equity shares of face value of Re.1/- aggregating to 800.00 crores ("offered shares") by the selling shareholders, consisting of 3,567,670 equity shares of face value of Re.1/- aggregating to 211.56 crores by SujitJjaysukh Bhayani, 8,418,856 equity shares of face value of Re.1/- aggregating to 499.24 crores by Sujeet Jaysukh Bhayani HUF, 750,000 equity shares of face value of Re.1/- aggregating to 44.48 crores by Shanil Sujit Bhayani and 754,200 equity shares of face value of Re.1/- aggregating to 44.72 crores by Avani Sujit Bhayani (collectively "the selling shareholders") and such equity shares offered by the selling shareholders ("offer for sale", and together with the fresh issue, the "offer"). Price Band: 593/- for equity share of face value of 1 each. The floor price is 593 times times the face value times of the face value of the equity shares. Bids can made for a minimum of 25 equity shares and in multiples of 25 equity shares thereafter.

Issue Money Payable On
Opens On Closes On Application Allotment
21-Nov-25 25-Nov-25 Rs593.00-0.00 Rs0.00-0.00
Minimum Application for shares in Nos :25  Further Multiples of :25

  RsCr Lead Managers to the Issue
Project Cost 88.48
ICICI Securities Limited
Project Financed through Current Offer 895.00  
Post Issue Equity Share Capital 11.29  
Issue Price Rs593.00  
 
Projects
 Capital expenditure towards procurement of machinery for our production line located at Nandesari Facility I General corporate purposes
Promoted By
 Sujit Jaysukh Bhayani
 Avani Sujit Bhayani
 Shanil Sujit Bhayani
Listing At
 BSE 
 NSE 
Registrar to the Issue
 MUFG Intime India Pvt Ltd